SMTL ID : 4zzm.1

Human ERK2 in complex with an irreversible inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.89 Å

Oligo State

monomer

Ligands

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: R.181, R.184, Y.223 5 PLIP interactions: 5 interactions with chain A Water bridges: A:R.181, A:R.181, A:Y.223 Salt bridges: A:R.181, A:R.184

1 x CQ6: 7-ETHYLSULFONYL-N-(OXAN-4-YL)-6,8-DIHYDRO-5H-PYRIDO[3,4-D]PYRIMIDIN-2-AMINE(Covalent)

CQ6.2: 14 residues within 4Å: Chain A: I.21, A.42, K.44, Q.95, D.96, L.97, M.98, E.99, T.100, D.101, N.144, L.146, C.156, D.157 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:A.42, A:L.146, A:L.146, A:D.157 Hydrogen bonds: A:K.44, A:M.98, A:M.98 Water bridges: A:D.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ward, R.A. et al., Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of Erk1/2. J.Med.Chem. (2015)

Release Date

2015-05-27

Peptides

MITOGEN-ACTIVATED PROTEIN KINASE 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MITOGEN-ACTIVATED PROTEIN KINASE 1

Related Entries With Identical Sequence